Key points are not available for this paper at this time.
Design
Review
Answers are grounded in this paper and cite their sources.
Advises caution with nonspecific AMI markers; leaves open validation of cardiac-specific alternatives.
Biochemical markers are substances that are detected in body fluids or tissues that may signify a disease or other abnormality. Biochemical markers have been used to help in the diagnosis of acute myocardial infarction since the 1950s. The major problem with these markers is that they lack specificity for cardiac muscle as they are also elevated in many disease states and after minor muscle damage.
No takes yet. Share an insight, caveat, or question.
Mary Gavaghan (1999) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: